EarningsORIONPHARM
ORIONPHARM Earnings Update
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 15 November 2018. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 0.98 for July-September, 2018 as against Tk. 1.10 for July-September, 2017; Consolidated NOCFPS was Tk. 2.62 for July-September, 2018 as against Tk. 2.53 for July-September, 2017. Consolidated NAV per share (including revaluation surplus) was Tk. 73.65 as on September 30, 2018 and Tk. 72.05 as on September 30, 2017. Consolidated NAV per share (excluding revaluation surplus) was Tk. 65.35 as on September 30, 2018 and Tk. 63.62 as on September 30, 2017.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aced55a6b00004005b39a
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.